AKAY’s R&D published a new human study about the anti-inflammatory effect of CurQfen against oxidised low-density lipoprotein (ox-LDL) induced inflammatory responses in human peripheral blood mononuclear cells. CurQfen is found to down-regulate and reverse the ox-LDL-induced alterations indicating its potential anti-inflammatory effect. The low-density lipoprotein (ox-LDL) is recently identified as a key risk factor in cardiovascular diseases (Pawlak et al. 2012). The results of the study indicated that CurQfen has significant anti-inflammatory effect on ox-LDL-induced inflammatory condition, as evident from the biochemical assays and gene expression analysis. The study concludes that CurQfen is a safe antioxidant-rich natural formulation of curcumin, possessing potent anti-inflammatory effect and might have implications for strategies that aim to prevent and attenuate cardiovascular diseases, especially atherosclerosis.
Click here to learn more.